162 related articles for article (PubMed ID: 36443992)
1. Expression of m
Zhang D; Zhang D; Yang X; Li Q; Zhang R; Xiong Y
Cartilage; 2023 Sep; 14(3):321-328. PubMed ID: 36443992
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immune microenvironment infiltration and m
Ouyang Y; Tu Y; Chen S; Min H; Wen Z; Zheng G; Wan T; Fan H; Yang W; Sun G
Front Immunol; 2022; 13():1018701. PubMed ID: 36505479
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern analysis of m6A regulators reveals IGF2BP3 as a key modulator in osteoarthritis synovial macrophages.
Lu Y; Zhang H; Pan H; Zhang Z; Zeng H; Xie H; Yin J; Tang W; Lin R; Zeng C; Cai D
J Transl Med; 2023 May; 21(1):339. PubMed ID: 37217897
[TBL] [Abstract][Full Text] [Related]
4. Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation.
Jin L; Ma J; Chen Z; Wang F; Li Z; Shang Z; Dong J
BMC Med Genomics; 2023 Jul; 16(1):163. PubMed ID: 37434153
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis.
Chen Z; Wang W; Hua Y
Front Immunol; 2023; 14():1019445. PubMed ID: 37006267
[TBL] [Abstract][Full Text] [Related]
6. U-shaped association between serum IGF2BP3 and T2DM: A cross-sectional study in Chinese population.
Wu X; Wang W; Fan S; You L; Li F; Zhang X; Wu H; Tang J; Qi Y; Feng W; Yan L; Ren M
J Diabetes; 2023 Apr; 15(4):349-361. PubMed ID: 36891946
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis.
Liu Z; Liu H; Li D; Ma L; Lu T; Sun H; Zhang Y; Yang H
Front Immunol; 2023; 14():1128459. PubMed ID: 37006311
[TBL] [Abstract][Full Text] [Related]
8. Analysis of gene expression and methylation datasets identified ADAMTS9, FKBP5, and PFKBF3 as biomarkers for osteoarthritis.
Li Z; Zhang R; Yang X; Zhang D; Li B; Zhang D; Li Q; Xiong Y
J Cell Physiol; 2019 Jun; 234(6):8908-8917. PubMed ID: 30317616
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic, progressive and prognostic performance of m
Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
[No Abstract] [Full Text] [Related]
10. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
11. Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas.
Sun C; Zheng X; Sun Y; Yu J; Sheng M; Yan S; Zhu Q; Lan Q
Front Genet; 2021; 12():743738. PubMed ID: 34721530
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
14. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
15. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
16. Identification and Molecular Mechanisms Study of Genes Associated with Osteoarthritis: A Comprehensive Bioinformatic Study of Cartilage and Synovium.
Li S; Wang X; Li J; Wei W; Liu J
Crit Rev Eukaryot Gene Expr; 2022; 32(2):25-38. PubMed ID: 35381129
[TBL] [Abstract][Full Text] [Related]
17. m6A regulator-mediated methylation modification patterns and immune microenvironment infiltration characterization in osteoarthritis.
Hu S; Shen C; Yao X; Zou Y; Wang T; Sun X; Nie M
BMC Med Genomics; 2022 Dec; 15(1):273. PubMed ID: 36585683
[TBL] [Abstract][Full Text] [Related]
18. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Li Z; Li F; Peng Y; Fang J; Zhou J
Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
[TBL] [Abstract][Full Text] [Related]
19. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
20. Identification of m7G-related hub biomarkers and m7G regulator expression pattern in immune landscape during the progression of osteoarthritis.
Chen Z; Hua Y
Cytokine; 2023 Oct; 170():156313. PubMed ID: 37549488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
